PABPN1 (GCN)11 as a Dominant Allele in Oculopharyngeal Muscular Dystrophy -Consequences in Clinical Diagnosis and Genetic Counselling
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expansion of the PABPN1 protein occurs within an amino (N) terminal 10-residue alanine tract resulting in the addition of 1–8 alanine residues [1,4,5].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes
Blumen, S. C., Bouchard, J. P., Brais, B., Carasso, R. L., Paleacu, D., Drory, V. E., Chantal, S., Blumen, N., & Braverman, I. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b388a3 · Cited by 54 · cited 1×
“Keywords: Oculopharyngeal muscular dystrophy, genetics, PABPN1 gene”
Research works printed but not linked: 23
- Taylor, 1915, Progressive vagus-glossopharyngeal paralysis with ptosis: A contribution to the group family diseases, J Nerv Ment Dis, 129, 10.1097/00005053-191503000-00001 · doi:10.1097/00005053-191503000-00001
- Victor, 1962, Oculopharyngeal muscular dystrophy. A familial disease of late life characterized by dysphagia and progressive ptosis of the evelids, N Engl J Med, 267, 1267, 10.1056/NEJM196212202672501 · doi:10.1056/nejm196212202672501
- Bouchard, 1997, Recent studies on oculopharyngeal muscular dystrophy in Quebec, Neuromuscul Disord, 1, S22, 10.1016/S0960-8966(97)00077-1 · doi:10.1016/s0960-8966(97)00077-1
- Hill, 2001, Oculopharyngeal muscular dystrophy: Phenotypic and genotypic studies in a UK population, Brain, 124, 522, 10.1093/brain/124.3.522 · doi:10.1093/brain/124.3.522
- Witting, 2014, Ocular, bulbar, limb, and cardiopulmonary involvement in oculopharyngeal muscular dystrophy, Acta Neurol Scand, 130, 125, 10.1111/ane.12244 · doi:10.1111/ane.12244
- Van Der Sluijs, 2003, Oculopharyngeal muscular dystrophy with limb girdle weakness as major complaint, J Neurol, 250, 1307, 10.1007/s00415-003-0201-6 · doi:10.1007/s00415-003-0201-6
- Brais, 2003, Oculopharyngeal muscular dystrophy: A late-onset polyalanine disease, Cytogenet Genome Res, 100, 252, 10.1159/000072861 · DOI
- Blumen, 1999, Homozygotes for oculopharyngeal muscular dystrophy have a severe form of the disease, Ann Neurol, 46, 115, 10.1002/1531-8249(199907)46:1<115::AID-ANA17>3.0.CO;2-O · doi:10.1002/1531-8249(199907)46:1<115::aid-ana17>3.0.co;2-o
- Dubbioso, 2012, Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy, J Neurol, 259, 833, 10.1007/s00415-011-6255-y · DOI
- Mizoi, 2011, Oculopharyngeal muscular dystrophy associated with dementia, Intern Med, 50, 2409, 10.2169/internalmedicine.50.5577 · DOI
- Brais, 1998, Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy, Nat Genet, 18, 164, 10.1038/ng0298-164 · DOI · Paper page
- Tome, 1980, Nuclear inclusions in oculopharyngeal dystrophy, Acta Neuropathol, 49, 85, 10.1007/BF00692226 · DOI
- Mirabella, 2000, GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy, Neurology, 54, 608, 10.1212/WNL.54.3.608 · doi:10.1212/wnl.54.3.608
- Muller, 2006, Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy, J Neurol, 253, 892, 10.1007/s00415-006-0126-y · DOI
- Robinson, 2005, Oculopharyngeal muscular dystrophy (OPMD): Analysis of the PABPN1 gene expansion sequence in 86 patients reveals 13 different expansion types and further evidence for unequal recombination as the mutational mechanism, Hum Genet, 116, 267, 10.1007/s00439-004-1235-2 · DOI
- Tondo, 2012, Genotype and phenotype study of 34 Spanish patients diagnosed with oculopharyngeal muscular dystrophy, J Neurol, 259, 1546, 10.1007/s00415-011-6374-5 · doi:10.1007/s00415-011-6374-5
- Semmler, 2007, Variability of the recessive oculopharyngeal muscular dystrophy phenotype, Muscle Nerve, 35, 681, 10.1002/mus.20726 · doi:10.1002/mus.20726
- Hebbar, 2007, Siblings with recessive oculopharyngeal muscular dystrophy, Neuromuscul Disord, 17, 254, 10.1016/j.nmd.2006.11.009 · doi:10.1016/j.nmd.2006.11.009
- Gidaro, 2013, Atrophy, Fibrosis, and Increased PAX7-Positive Cells in Pharyngeal Muscles of Oculopharyngeal Muscular Dystrophy Patients, J Neuropathol Exp Neurol, 72, 234, 10.1097/NEN.0b013e3182854c07 · DOI
- Marsh, 2008, A case of rare recessive oculopharyngeal muscular dystrophy (OPMD) coexisting with hereditary neuropathy with liability to pressure palsies (HNPP), Clin Neurol Neurosurg, 110, 525, 10.1016/j.clineuro.2008.02.007 · doi:10.1016/j.clineuro.2008.02.007
- Agarwal, 2012, Delayed diagnosis of oculopharyngeal muscular dystrophy in Scotland, Br J Ophthalmol, 96, 281, 10.1136/bjo.2010.200378 · doi:10.1136/bjo.2010.200378
- Chien, 2012, Oculopharyngeal muscular dystrophy –an under-diagnosed disease in China? Report a China-born Chinese with PABPN1 mutation and epidemiology review of the literature, J Formos Med Assoc, 111, 397, 10.1016/j.jfma.2011.06.017 · doi:10.1016/j.jfma.2011.06.017
- Raz, 2013, 191st ENMC International Workshop: Recent advances in oculopharyngeal muscular dystrophy research: From bench to bedside 8-10 June Naarden, The Netherlands, Neuromuscul Disord, 23, 516, 10.1016/j.nmd.2013.03.001 · DOI
Cited by
Mezzell, A. T., Zhang, Y., Perez, A. M., & Vest, K. E. (2026) · PLOS Genetics · doi:10.1371/journal.pgen.1011743 · Cited by 7
Metadata
- Authors
- Richard, P., Trollet, C., Gidaro, T., Demay, L., Brochier, G., Malfatti, E., Tom, F. M., Fardeau, M., Lafor, P., Romero, N., Martin-N, M.-L., Sol, G., Ferrer-Monasterio, X., Saint-Guily, J. L., & Eymard, B.
- Affiliations
- APHP, Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, Service de Biochimie M?bolique, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, 47-83, bld de l’hôpital, Paris cedex 13, France/UMRS 956-UPMC, Paris 6, France
- Sorbonne Universités, UPMC Univ Paris 06, UM76, INSERM U974, Institut de Myologie, CNRS FRE3617, 47 bd de l’Hôpital,Paris, France
- APHP, Unité de Morphologie Neuromusculaire, Pavillon Risler, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Paris, France
- CHU de Bordeaux, Centre de Référence des Maladies Neuromusculaires, Hôpital Pellegrin, Place Amelie Raba Leon, Bordeaux, France
- APHP, Service d’ORL et chirurgie cervicofaciale, hôpital Tenon, UPMC Université Paris 6, 4 rue de la Chine, Paris, France
- APHP, Centre de Référence des Maladies Neuromusculaires Paris Est, Unité de Morphologie Neuromusculaire, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, -83, bld de l’hôpital, Paris cedex 13, France
- Venue
- Journal of Neuromuscular Diseases
- Publisher
- SAGE Publications
- Published
- 2015-06-04
- Volume
- 2
- Issue
- 2
- Pages
- 175-180
- ISSN
- 2214-3599
- 2214-3602
- Cited by
- 38
- References
- 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.